Show simple item record

BNT162b2 COVID-19 vaccination uptake, safety, effectiveness and waning in children and young people aged 12–17 years in Scotland

dc.contributor.authorRudan, Igor
dc.contributor.authorMillington, Tristan
dc.contributor.authorAntal, Karen
dc.contributor.authorGrange, Zoe
dc.contributor.authorFenton, Lynda
dc.contributor.authorSullivan, Christopher
dc.contributor.authorBuelo, Audrey
dc.contributor.authorWood, Rachael
dc.contributor.authorWoolford, Lana
dc.contributor.authorSwann, Olivia V.
dc.contributor.authorMurray, Josephine L.K.
dc.contributor.authorCullen, Lucy A.
dc.contributor.authorMoore, Emily
dc.contributor.authorHaider, Fasih
dc.contributor.authorAlmaghrabi, Fatima
dc.contributor.authorMcMenamin, Jim
dc.contributor.authorAgrawal, Utkarsh
dc.contributor.authorShah, Syed Ahmar
dc.contributor.authorKerr, Steven
dc.contributor.authorSimpson, Colin R.
dc.contributor.authorKatikireddi, Srinivasa Vittal
dc.contributor.authorRitchie, Sir Lewis D.
dc.contributor.authorRobertson, Chris
dc.contributor.authorSheikh, Sir Aziz
dc.date.accessioned2022-11-02T00:09:16Z
dc.date.available2022-11-02T00:09:16Z
dc.date.issued2022-12
dc.identifier219651798
dc.identifier9301cbfc-dab9-4e02-9547-aec0beb79c09
dc.identifier85138832636
dc.identifier.citationRudan , I , Millington , T , Antal , K , Grange , Z , Fenton , L , Sullivan , C , Buelo , A , Wood , R , Woolford , L , Swann , O V , Murray , J L K , Cullen , L A , Moore , E , Haider , F , Almaghrabi , F , McMenamin , J , Agrawal , U , Shah , S A , Kerr , S , Simpson , C R , Katikireddi , S V , Ritchie , S L D , Robertson , C & Sheikh , S A 2022 , ' BNT162b2 COVID-19 vaccination uptake, safety, effectiveness and waning in children and young people aged 12–17 years in Scotland ' , The Lancet Regional Health - Europe , vol. 23 , 100513 . https://doi.org/10.1016/j.lanepe.2022.100513en
dc.identifier.issn2666-7762
dc.identifier.otherRIS: urn:76913292C54E98933C4D0808040B4145
dc.identifier.urihttp://aura-test.abdn.ac.uk/handle/2164/19244
dc.descriptionThis study is part of the EAVE II project. EAVE II is funded by the MRC (MC_PC_19075) with the support of BREATHE—The Health Data Research Hub for Respiratory Health (MC_PC_19004), which is funded through the UK Research and Innovation Industrial Strategy Challenge Fund and delivered through the Health Data Research UK. This research is part of the Data and Connectivity National Core Study, led by Health Data Research UK in partnership with the Office for National Statistics and funded by UK Research and Innovation (grant ref MC_PC_20058). This work was also supported by The Alan Turing Institute via ‘Towards Turing 2.0’ EPSRC Grant Funding. Additional support has been provided through Public Health Scotland, the Scottish Government Director-General Health and Social Care and the University of Edinburgh. The original EAVE project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme (11/46/23). The views expressed are those of the authors and not necessarily those of the NIHR, the Department of Health and Social Care, or the UK government. We thank Dave Kelly from Albasoft (Inverness, UK) for his support with making primary care data available, and Wendy Inglis-Humphrey, Vicky Hammersley, and Laura Brook (University of Edinburgh, Edinburgh, UK) for their support with project management and administration.en
dc.format.extent16
dc.format.extent550150
dc.language.isoeng
dc.relation.ispartofThe Lancet Regional Health - Europeen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectSDG 9 - Industry, Innovation, and Infrastructureen
dc.subjectCOVID-19en
dc.subjectBNT162b2 COVID-19 vaccinationen
dc.subjectVaccine uptakeen
dc.subjectVaccine safetyen
dc.subjectVaccine effectivenessen
dc.subjectVaccine waningen
dc.subjectChildren and young peopleen
dc.subjectAge group 12-15 yearsen
dc.subjectAge group 16-17 yearsen
dc.subjectScotlanden
dc.subjectUnited Kingdomen
dc.subjectNational prospective cohort studyen
dc.subjectR Medicineen
dc.subjectMedical Research Council (MRC)en
dc.subjectSupplementary Dataen
dc.subjectMC_PC_19075en
dc.subjectMC_PC_20058en
dc.subject.lccRen
dc.titleBNT162b2 COVID-19 vaccination uptake, safety, effectiveness and waning in children and young people aged 12–17 years in Scotlanden
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Medical Educationen
dc.contributor.institutionUniversity of Aberdeen.Medicine, Medical Sciences & Nutritionen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.identifier.doihttps://doi.org/10.1016/j.lanepe.2022.100513
dc.identifier.vol23en


Files in this item

Thumbnail
Name:
Vargesson_etal_EODS_Thalidomid ...
Size:
80.31Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record